User profiles for Surakameth Mahasirimongkol
Surakameth MahasirimongkolMedical Life Sciences Institute (MLSI), Department of Medical Sciences, Ministry of Public … Verified email at dmsc.mail.go.th Cited by 3665 |
Global implementation of genomic medicine: we are not alone
…, P Lasko, E Leego, S Mahasirimongkol… - Science translational …, 2015 - science.org
Around the world, innovative genomic-medicine programs capitalize on singular capabilities
arising from local health care systems, cultural or political milieus, and unusual selected risk …
arising from local health care systems, cultural or political milieus, and unusual selected risk …
A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
…, S Svasti, T Munkongdee, S Mahasirimongkol… - Human genetics, 2010 - Springer
β-Thalassemia/HbE disease is clinically variable. In searching for genetic factors modifying
the disease severity, patients were selected based on their disease severities, and a genome…
the disease severity, patients were selected based on their disease severities, and a genome…
HLA-B* 3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients
…, T Mushiroda, S Mahasirimongkol… - Pharmacogenetics …, 2009 - journals.lww.com
Objective Investigation of a possible involvement of differences in human leukocyte antigens
(HLA) in the risk of nevirapine (NVP)-induced skin rash among HIV-infected patients. …
(HLA) in the risk of nevirapine (NVP)-induced skin rash among HIV-infected patients. …
Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis
S Mahasirimongkol, H Yanai, T Mushiroda… - Journal of human …, 2012 - nature.com
Tuberculosis (TB) is one of the most devastating chronic infectious diseases, but the role of
host genetics in disease development after infection in this disease remains unidentified. …
host genetics in disease development after infection in this disease remains unidentified. …
Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population
…, A Sangviroon, S Mahasirimongkol… - Pharmacogenetics …, 2016 - journals.lww.com
Background Phenytoin is one of the most common causative drugs of several types of severe
cutaneous adverse reactions (SCAR) such as Stevens–Johnson syndrome (SJS), toxic …
cutaneous adverse reactions (SCAR) such as Stevens–Johnson syndrome (SJS), toxic …
Immunogenicity and safety of an intradermal BNT162b2 mRNA vaccine booster after two doses of inactivated SARS-CoV-2 vaccine in healthy population
…, S Uppanisakorn, S Mahasirimongkol… - Vaccines, 2021 - mdpi.com
Effective vaccine coverage is urgently needed to tackle the COVID-19 pandemic. Inactivated
vaccines have been introduced in many countries for emergency usage, but have only …
vaccines have been introduced in many countries for emergency usage, but have only …
Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions
T Kongpan, S Mahasirimongkol… - Pharmacogenetics …, 2015 - journals.lww.com
Background Co-trimoxazole is a sulfonamide-containing antibiotic that is effective in the
treatment of several infections and for prophylaxis of Pneumocystis jiroveci pneumonia. This …
treatment of several infections and for prophylaxis of Pneumocystis jiroveci pneumonia. This …
Genome-wide host-pathogen analyses reveal genetic interaction points in tuberculosis disease
…, M Kubo, K Tokunaga, S Mahasirimongkol… - Nature …, 2023 - nature.com
The genetics underlying tuberculosis (TB) pathophysiology are poorly understood. Human
genome-wide association studies have failed so far to reveal reproducible susceptibility loci, …
genome-wide association studies have failed so far to reveal reproducible susceptibility loci, …
Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study
…, S Mahasirimongkol… - Emerging Microbes & …, 2022 - Taylor & Francis
We investigated Favipiravir (FPV) efficacy in mild cases of COVID-19 without pneumonia
and its effects towards viral clearance, clinical condition, and risk of COVID-19 pneumonia …
and its effects towards viral clearance, clinical condition, and risk of COVID-19 pneumonia …
NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients
…, S Suvichapanich, S Mahasirimongkol… - … of Tuberculosis and …, 2016 - ingentaconnect.com
BACKGROUND: Anti-tuberculosis drug-induced liver injury (AT-DILI) is one of the most
common forms of drug-induced liver injury (DILI) in high tuberculosis (TB) burden countries. …
common forms of drug-induced liver injury (DILI) in high tuberculosis (TB) burden countries. …